Canada Is Reviewing Its Industrial Hemp Regulations — Here’s Why Your Input Matters

Canada’s Industrial Hemp Regulations have been the foundational legal framework for this industry since 1998, and in nearly three decades, they have shaped how we grow, test, license, and bring new varieties to market as producers, operators, breeders, and agronomists. They have also, in many respects, remained largely unchanged while the hemp industry evolved considerably around them.

That is now under review. On May 16, 2026, Health Canada published a Notice of Intent in the Canada Gazette, Part I, signalling its intention to examine potential amendments to the Industrial Hemp Regulations (IHR), with a public comment period running until June 30, 2026: 45 days to put operational experience on the record. I will acknowledge that the timing is not ideal: Canadian hemp producers are in the middle of peak planting season, breeders and agronomists are finalising field trial plans, and seed labs are working through germination and related tests for planting seed. And yet, for Canadian hemp industry stakeholders this is not a routine regulatory notice. I believe it is a genuinely rare opportunity — one that we cannot afford to let pass unacknowledged.

What Health Canada is looking at

Health Canada has published six guiding questions covering the full scope of where the IHR may be reformed: regulatory burden across cultivation, import and export, THC testing, the sale of flowering parts, and reporting requirements; what control measures must be preserved to prevent illicit diversion; what should be eliminated or reduced and why; whether the definition of industrial hemp itself should change; how LOAC management could be streamlined; and whether reducing the regulatory burden carries any public health or safety risks.

The scope of these six questions is itself worth noting. Rather than proposing narrow technical fixes, Health Canada has opened the full architecture of the IHR to review: from the THC basis for industrial hemp definition, to LOAC management, to licensing structure. I believe that reflects a regulator that has been listening to industry concerns with some care, and that this consultation is designed to receive substantive input, not simply to fulfil a procedural requirement.

Let us look at these questions:

The 0.3% THC threshold

The current definition of industrial hemp under the IHR is tied to a maximum THC concentration of 0.3% in the flowering heads and leaves at harvest, and Health Canada is asking whether this threshold should be revisited.

I would suggest that this question is more technically layered than it might appear from the outside. The 0.3% threshold affects which varieties can be grown commercially, how compliance testing is structured, how trial data is interpreted for LOAC applications, and how Canada aligns with its international trading partners. Anyone who has managed THC compliance testing across multiple growing seasons — dealing with the variability that comes with environmental conditions, harvest timing, and laboratory methodology — understands that the practical implications of any threshold change are not straightforward. That operational knowledge is precisely what this consultation needs to hear.

The List of Approved Cultivars

The LOAC is the gateway to commercial hemp production in Canada. A variety must appear on the list before it can be legally cultivated under an IHR licence, and Health Canada is asking how the LOAC process — including how varieties are evaluated, added, maintained, and potentially removed — could be streamlined.

The current process is rigorous by design: it involves field evaluation trials, THC compliance testing across multiple seasons, and formal data submissions before a variety reaches approved status. That rigour exists for legitimate reasons, protecting the integrity of the list and, by extension, the credibility of the industry as a whole. Any streamlining involves trade-offs, and I believe both sides of that equation deserve to be on the record. Speed and accessibility are genuinely valuable; so is the confidence that every variety on the list has been properly evaluated. Producers, seed companies, and plant breeders who have worked through this process have direct experience of where it functions well and where it creates friction that does not serve its intended purpose. I firmly believe that distinction — between productive rigour and unnecessary burden — is exactly what Health Canada is trying to understand.

Licensing and testing requirements

Health Canada is also asking which licensing requirements — around cultivation, processing, import, export, and THC testing — impose a regulatory burden that is not proportionate to the actual risks involved.

I believe this is the area where the gap between regulatory design and operational reality is most visible to the people running hemp operations day to day. Licensing timelines, testing frequency, record-keeping obligations, and the administrative requirements attached to each licence category all carry real costs: some of that structure serves clear public safety purposes, and some of it may be legacy overhead that made sense under earlier assumptions about this industry and has simply not been formally revisited since. Canadian operators are in the best position to identify which is which, and that distinction is precisely what Health Canada needs to hear.

Why your response matters

Consultations like this one are not just procedural. The feedback Health Canada receives will be used to develop a Regulatory Impact Analysis Statement, which will inform any proposed amendments, and the regulations that come out of this process will reflect the input that was submitted — or the absence of it.

Yes, we are all extraordinarily busy at this time of year right across the country, and I say that as someone who is equally deep in the season. Whether you are a producer in the middle of planting, a breeder finalising field trial plans, an agronomist working through crop establishment, or in any of the many other roles that keep this industry moving forward, it is precisely that shared operational reality that makes our participation in this consultation so important. We grow and produce safe, high-quality crops and seed, and we want to continue to do that well into the future. The most effective way to protect that ability is to be part of the conversation that shapes the rules governing it — from a position of demonstrated operational expertise, not as observers after decisions have already been made.

The people with the most relevant evidence are the ones managing licensed operations, running trials, navigating LOAC submissions, and carrying the practical weight of compliance year over year. If Canadian hemp industry stakeholders do not respond, that evidence gap does not disappear; it gets filled by other voices, or by assumptions. The consultation is designed specifically to hear from practitioners, and I think it is worth taking that invitation seriously.

A submission does not need to address all six questions, and it does not need to be lengthy or formally structured. What Health Canada is asking for is substantive input grounded in real operational experience: a clear account of where the current regulations work, where they create friction, and why — from someone who lives inside them. That is exactly the kind of response that shapes better policy.

One additional note for industrial hemp licence holders specifically: Health Canada is also distributing a separate voluntary cost-benefit analysis questionnaire directly to licence holders. If you receive it, I would encourage you to respond to both: the questionnaire and the Public Consultation. The questionnaire data feeds directly into the Regulatory Impact Analysis Statement that will accompany any proposed amendments, so both channels matter.

How to participate

The Notice of Intent and further information are available on the Health Canada updates page for cannabis and industrial hemp.

The IHR have governed this industry for nearly three decades, and the people who have built operations, developed varieties, navigated LOAC submissions, and carried the weight of compliance across seasons have earned the standing to say what is working and what needs to change. I firmly believe that better regulations, properly shaped by those who live inside them every day, will strengthen this industry’s foundation and create a more sustainable, competitive, and credible Canadian hemp sector for years to come. The window to make that case is open until June 30.